TECH Bio-Techne Corporation
Healthcare
Price
$72.11
Intrinsic value
$12.25
Buy price
$9.80
Discount
-488.5%
DCF walkthrough
Near-term growth (g1)0.00%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $294,858,000.00
- Total debt
- $290,321,984.00
- Cash & STI
- $214,114,000.00
- Shares out.
- 157,403,000
Overvalued [LOW CF reliability]
Intrinsic value$12.25
Buy price (with MOS)$9.80
Current price$72.11
Discount to intrinsic value-488.5%
7-step quality scorecard
ROE quality
LOW- Average ROE
- 10.6%
- Current ROE
- 3.8%
- Minimum ROE
- 3.8%
Debt quality
CONSERVATIVE- Debt / Equity
- 0.15x
Moat proxy
WEAK_PROXYCash-flow reliability
LOW- Operating CF / Net income
- 2.69x
Technical chart
Confluence: NONE (0/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- min(cfCAGR,revenueCAGR)
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 14.5%
- Public economic interest
- 100.0%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.